Can MDMA Really Cure Tinnitus?

Tinnitus, the condition that is characterized by ringing or uncontrollable noise disturbance in the ears, could possibly be cured with MDMA. The revelation comes from a scientific study being conducted in New Zealand, which has already completed trials showing promise of proving that the common rave/party drug could be used to cure the troubling hearing condition.

As reported by Stuffthe joint study between the University of Auckland and the University of Otago began two years ago as a result of enough reports from those with tinnitus who had taken ecstasy and felt benefits, urging researches to dig into it further.

So far, the last two years of MDMA studies involved a small number of participants in placebo-controlled trials, where they were given a small dose of MDMA or a placebo and monitored over a four-hour time period. It’s important to not that they were not given enough MDMA to feel high”, yet many reported an easing of tinnitus after just three hours. Reportedly, those who experienced the benefits stated that the same effects maintained for a week or even more. The research conducted thus far was divided into two separate trials, where researchers administered doses of 30 mg or 70 mg of MDMA imported under strict controls and dispensed by pharmacists working as part of the research team.

The leading professor behind the research, University of Auckland professor Grant Searchfield, did note that the operation is moving slow due to the high risks associated with MDMA, “Our goal is to try and find a medication for tinnitus. It can have catastrophic effects. Whether MDMA is it or whether it’s a trial for us to identify what is going on in the brain is still an open question.”

In order for the study to continue, as well as to know which exact next steps are needed, Scientists are reviewing all data and brain imaging from the trials thus far conduced, which could take months. Further funding will also need to be raised in order to progress beyond the current stage of the trials.